CSL secured rights to MSD's vaccines in Australia and New Zealand as part of an agreement negotiated in the 1990s under which the US company gained global development and commercialisation rights to the investigative candidate that became GARDASIL.
MSD to bring vaccine distribution back in-house after 40-year partnership
December 1, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
MSD to bring vaccine distribution back in-house after 40-year partnership
December 1, 2025 - - Latest News -
New PBS listing offers fresh hope for Australians living with debilitating skin condition
December 1, 2025 - - Latest News -
Five Australians honoured for leadership and community advocacy in evolving HIV response
December 1, 2025 - - Latest News -
Budget discipline tightens with agencies directed to target 'lowest priority work'
November 30, 2025 - - Latest News -
The 'Dispatched' Podcast - 30 November
November 30, 2025 - - Podcast -
Chimeric signals board refresh and shareholder support as lead trial advances
November 30, 2025 - - Australian Biotech -
Pharmac announces 90-day dispensed quantities of HIV medicines
November 27, 2025 - - Latest News
